Publication Information

{'id': 'https://openalex.org/W2786049742', 'doi': 'https://doi.org/10.1158/1535-7163.targ-17-a127', 'title': 'Abstract A127: The identification and development of selective natural product inhibitors of hypoxia inducible factor-2α for the treatment of renal cell carcinoma', 'display_name': 'Abstract A127: The identification and development of selective natural product inhibitors of hypoxia inducible factor-2α for the treatment of renal cell carcinoma', 'publication_year': 2018, 'publication_date': '2018-01-01', 'ids': {'openalex': 'https://openalex.org/W2786049742', 'doi': 'https://doi.org/10.1158/1535-7163.targ-17-a127', 'mag': '2786049742'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1535-7163.targ-17-a127', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S48437117', 'display_name': 'Molecular Cancer Therapeutics', 'issn_l': '1535-7163', 'issn': ['1535-7163', '1538-8514'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5078581988', 'display_name': 'Molly M. Lee', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210140884', 'display_name': 'National Cancer Institute', 'ror': 'https://ror.org/040gcmg81', 'country_code': 'US', 'type': 'government', 'lineage': ['https://openalex.org/I1299022934', 'https://openalex.org/I1299303238', 'https://openalex.org/I4210140884']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Molly M. Lee', 'raw_affiliation_strings': ['1National Cancer Institute, Bethesda, MD;'], 'affiliations': [{'raw_affiliation_string': '1National Cancer Institute, Bethesda, MD;', 'institution_ids': ['https://openalex.org/I4210140884']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5091688844', 'display_name': 'Daniel C. Rabe', 'orcid': 'https://orcid.org/0000-0001-6126-2280'}, 'institutions': [{'id': 'https://openalex.org/I4210140884', 'display_name': 'National Cancer Institute', 'ror': 'https://ror.org/040gcmg81', 'country_code': 'US', 'type': 'government', 'lineage': ['https://openalex.org/I1299022934', 'https://openalex.org/I1299303238', 'https://openalex.org/I4210140884']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Daniel C. Rabe', 'raw_affiliation_strings': ['1National Cancer Institute, Bethesda, MD;'], 'affiliations': [{'raw_affiliation_string': '1National Cancer Institute, Bethesda, MD;', 'institution_ids': ['https://openalex.org/I4210140884']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5029867843', 'display_name': 'Tawnya C. McKee', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210130649', 'display_name': 'Frederick National Laboratory for Cancer Research', 'ror': 'https://ror.org/03v6m3209', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I1299022934', 'https://openalex.org/I1299303238', 'https://openalex.org/I4210130649', 'https://openalex.org/I4210140884']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Tawnya C. McKee', 'raw_affiliation_strings': ['2Frederick National Laboratory for Cancer Research, Frederick, MD.'], 'affiliations': [{'raw_affiliation_string': '2Frederick National Laboratory for Cancer Research, Frederick, MD.', 'institution_ids': ['https://openalex.org/I4210130649']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5067388546', 'display_name': 'Girma M. Woldemichael', 'orcid': 'https://orcid.org/0000-0003-1823-1328'}, 'institutions': [{'id': 'https://openalex.org/I4210130649', 'display_name': 'Frederick National Laboratory for Cancer Research', 'ror': 'https://ror.org/03v6m3209', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I1299022934', 'https://openalex.org/I1299303238', 'https://openalex.org/I4210130649', 'https://openalex.org/I4210140884']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Girma M. Woldemichael', 'raw_affiliation_strings': ['2Frederick National Laboratory for Cancer Research, Frederick, MD.'], 'affiliations': [{'raw_affiliation_string': '2Frederick National Laboratory for Cancer Research, Frederick, MD.', 'institution_ids': ['https://openalex.org/I4210130649']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5110464295', 'display_name': 'James R. Vasselli', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210140884', 'display_name': 'National Cancer Institute', 'ror': 'https://ror.org/040gcmg81', 'country_code': 'US', 'type': 'government', 'lineage': ['https://openalex.org/I1299022934', 'https://openalex.org/I1299303238', 'https://openalex.org/I4210140884']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'James R. Vasselli', 'raw_affiliation_strings': ['1National Cancer Institute, Bethesda, MD;'], 'affiliations': [{'raw_affiliation_string': '1National Cancer Institute, Bethesda, MD;', 'institution_ids': ['https://openalex.org/I4210140884']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5031571077', 'display_name': 'James B. McMahon', 'orcid': 'https://orcid.org/0000-0001-6167-9094'}, 'institutions': [{'id': 'https://openalex.org/I4210130649', 'display_name': 'Frederick National Laboratory for Cancer Research', 'ror': 'https://ror.org/03v6m3209', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I1299022934', 'https://openalex.org/I1299303238', 'https://openalex.org/I4210130649', 'https://openalex.org/I4210140884']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'James B. McMahon', 'raw_affiliation_strings': ['2Frederick National Laboratory for Cancer Research, Frederick, MD.'], 'affiliations': [{'raw_affiliation_string': '2Frederick National Laboratory for Cancer Research, Frederick, MD.', 'institution_ids': ['https://openalex.org/I4210130649']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5085217465', 'display_name': 'W. Marston Linehan', 'orcid': 'https://orcid.org/0000-0001-7373-3916'}, 'institutions': [{'id': 'https://openalex.org/I4210140884', 'display_name': 'National Cancer Institute', 'ror': 'https://ror.org/040gcmg81', 'country_code': 'US', 'type': 'government', 'lineage': ['https://openalex.org/I1299022934', 'https://openalex.org/I1299303238', 'https://openalex.org/I4210140884']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'W. Marston Linehan', 'raw_affiliation_strings': ['1National Cancer Institute, Bethesda, MD;'], 'affiliations': [{'raw_affiliation_string': '1National Cancer Institute, Bethesda, MD;', 'institution_ids': ['https://openalex.org/I4210140884']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5047485406', 'display_name': 'Donald P. Bottaro', 'orcid': 'https://orcid.org/0000-0002-5057-5334'}, 'institutions': [{'id': 'https://openalex.org/I4210140884', 'display_name': 'National Cancer Institute', 'ror': 'https://ror.org/040gcmg81', 'country_code': 'US', 'type': 'government', 'lineage': ['https://openalex.org/I1299022934', 'https://openalex.org/I1299303238', 'https://openalex.org/I4210140884']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Donald P. Bottaro', 'raw_affiliation_strings': ['1National Cancer Institute, Bethesda, MD;'], 'affiliations': [{'raw_affiliation_string': '1National Cancer Institute, Bethesda, MD;', 'institution_ids': ['https://openalex.org/I4210140884']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 2, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.0, 'has_fulltext': False, 'cited_by_count': 0, 'citation_normalized_percentile': {'value': 0.0, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 0, 'max': 62}, 'biblio': {'volume': '17', 'issue': '1_Supplement', 'first_page': 'A127', 'last_page': 'A127'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10631', 'display_name': 'Cancer, Hypoxia, and Metabolism', 'score': 0.9995, 'subfield': {'id': 'https://openalex.org/subfields/1306', 'display_name': 'Cancer Research'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10631', 'display_name': 'Cancer, Hypoxia, and Metabolism', 'score': 0.9995, 'subfield': {'id': 'https://openalex.org/subfields/1306', 'display_name': 'Cancer Research'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T12996', 'display_name': 'Cancer Research and Treatments', 'score': 0.94, 'subfield': {'id': 'https://openalex.org/subfields/1305', 'display_name': 'Biotechnology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T12465', 'display_name': 'Cancer, Lipids, and Metabolism', 'score': 0.9389, 'subfield': {'id': 'https://openalex.org/subfields/1306', 'display_name': 'Cancer Research'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/hif1a', 'display_name': 'HIF1A', 'score': 0.68471956}, {'id': 'https://openalex.org/keywords/hypoxia-inducible-factors', 'display_name': 'Hypoxia-Inducible Factors', 'score': 0.6244333}], 'concepts': [{'id': 'https://openalex.org/C2781278892', 'wikidata': 'https://www.wikidata.org/wiki/Q18556340', 'display_name': 'Clear cell renal cell carcinoma', 'level': 3, 'score': 0.7283635}, {'id': 'https://openalex.org/C31194975', 'wikidata': 'https://www.wikidata.org/wiki/Q20970095', 'display_name': 'HIF1A', 'level': 3, 'score': 0.68471956}, {'id': 'https://openalex.org/C2780394083', 'wikidata': 'https://www.wikidata.org/wiki/Q539568', 'display_name': 'Angiogenesis', 'level': 2, 'score': 0.6562309}, {'id': 'https://openalex.org/C160450060', 'wikidata': 'https://www.wikidata.org/wiki/Q104598479', 'display_name': 'Hypoxia-inducible factors', 'level': 3, 'score': 0.6244333}, {'id': 'https://openalex.org/C502942594', 'wikidata': 'https://www.wikidata.org/wiki/Q3421914', 'display_name': 'Cancer research', 'level': 1, 'score': 0.61030966}, {'id': 'https://openalex.org/C555283112', 'wikidata': 'https://www.wikidata.org/wiki/Q1637543', 'display_name': 'Carcinogenesis', 'level': 3, 'score': 0.5747106}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.55388}, {'id': 'https://openalex.org/C2777025900', 'wikidata': 'https://www.wikidata.org/wiki/Q29725', 'display_name': 'Vascular endothelial growth factor', 'level': 3, 'score': 0.5060887}, {'id': 'https://openalex.org/C62112901', 'wikidata': 'https://www.wikidata.org/wiki/Q189159', 'display_name': 'Cell growth', 'level': 2, 'score': 0.5018344}, {'id': 'https://openalex.org/C2781018059', 'wikidata': 'https://www.wikidata.org/wiki/Q207609', 'display_name': 'Oncogene', 'level': 4, 'score': 0.4609644}, {'id': 'https://openalex.org/C81885089', 'wikidata': 'https://www.wikidata.org/wiki/Q189082', 'display_name': 'Cell culture', 'level': 2, 'score': 0.45505387}, {'id': 'https://openalex.org/C1491633281', 'wikidata': 'https://www.wikidata.org/wiki/Q7868', 'display_name': 'Cell', 'level': 2, 'score': 0.43387583}, {'id': 'https://openalex.org/C86339819', 'wikidata': 'https://www.wikidata.org/wiki/Q407384', 'display_name': 'Transcription factor', 'level': 3, 'score': 0.43328983}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.3494237}, {'id': 'https://openalex.org/C2777472916', 'wikidata': 'https://www.wikidata.org/wiki/Q1164529', 'display_name': 'Renal cell carcinoma', 'level': 2, 'score': 0.3003234}, {'id': 'https://openalex.org/C29537977', 'wikidata': 'https://www.wikidata.org/wiki/Q188941', 'display_name': 'Cell cycle', 'level': 3, 'score': 0.277801}, {'id': 'https://openalex.org/C104317684', 'wikidata': 'https://www.wikidata.org/wiki/Q7187', 'display_name': 'Gene', 'level': 2, 'score': 0.24708435}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.17970535}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.1680893}, {'id': 'https://openalex.org/C55493867', 'wikidata': 'https://www.wikidata.org/wiki/Q7094', 'display_name': 'Biochemistry', 'level': 1, 'score': 0.15862912}, {'id': 'https://openalex.org/C54355233', 'wikidata': 'https://www.wikidata.org/wiki/Q7162', 'display_name': 'Genetics', 'level': 1, 'score': 0.08200914}, {'id': 'https://openalex.org/C167734588', 'wikidata': 'https://www.wikidata.org/wiki/Q4356503', 'display_name': 'VEGF receptors', 'level': 2, 'score': 0.07673168}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1535-7163.targ-17-a127', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S48437117', 'display_name': 'Molecular Cancer Therapeutics', 'issn_l': '1535-7163', 'issn': ['1535-7163', '1538-8514'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'display_name': 'Good health and well-being', 'id': 'https://metadata.un.org/sdg/3', 'score': 0.43}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W4251360078', 'https://openalex.org/W4247038846', 'https://openalex.org/W4241716718', 'https://openalex.org/W4233046059', 'https://openalex.org/W4232585526', 'https://openalex.org/W3007761345', 'https://openalex.org/W2586355262', 'https://openalex.org/W2343761586', 'https://openalex.org/W1990660527', 'https://openalex.org/W1976047739'], 'abstract_inverted_index': {'Abstract': [0], 'Clear': [1], 'cell': [2, 4, 150, 205, 254, 431], 'renal': [3, 430], 'carcinoma': [5, 432], '(ccRCC)': [6], 'is': [7, 16, 57, 65, 95], 'the': [8, 30, 34, 136, 147, 160, 287, 298, 329, 333, 343, 349, 372, 427, 437], 'most': [9], 'prevalent': [10], 'form': [11], 'of': [12, 21, 33, 55, 84, 88, 93, 135, 146, 159, 232, 242, 245, 300, 328, 342, 378, 417, 422, 429, 436], 'kidney': [13], 'cancer': [14], 'and': [15, 46, 63, 91, 126, 179, 203, 222, 226, 248, 277, 279, 305, 348, 374, 380, 415, 443], 'frequently': [17], 'associated': [18, 97], 'with': [19, 98, 176, 195], 'loss': [20], 'von': [22], 'Hippel': [23], 'Lindau': [24], '(VHL)': [25], 'gene': [26, 167], 'function,': [27], 'resulting': [28], 'in': [29, 73, 110, 253, 357, 382], 'aberrant': [31], 'accumulation': [32], 'hypoxia': [35, 423], 'inducible': [36, 424], 'factor-alpha': [37], 'subunit': [38], '(HIF-α),': [39], 'which': [40], 'contributes': [41], 'to': [42, 60, 67, 171, 215, 257, 266, 296, 302, 321, 324, 354, 360], 'tumor': [43, 71], 'growth,': [44], 'angiogenesis,': [45], 'metastasis.': [47], 'Recent': [48], 'studies': [49, 341], 'suggest': [50], 'that': [51], 'this': [52, 102], 'normoxic': [53, 239], 'stabilization': [54], 'HIF-1α': [56, 64, 306], 'not': [58], 'sufficient': [59], 'reproduce': [61], 'tumorigenesis,': [62], 'thought': [66], 'act': [68], 'as': [69, 78, 123, 337], 'a': [70, 85, 130, 154, 325, 338], 'suppressor': [72], 'ccRCC.': [74], 'Conversely,': [75], 'HIF-2α': [76, 94, 105, 118, 281, 304, 310, 364], 'acts': [77], 'an': [79, 358], 'oncogene,': [80], 'turning': [81], 'on': [82], 'transcription': [83, 276], 'large': [86], 'number': [87], 'HIF-regulated': [89], 'genes,': [90], 'upregulation': [92], 'often': [96], 'poor': [99], 'prognosis.': [100], 'To': [101, 115, 284], 'end,': [103], 'two': [104], 'selective': [106, 119, 311, 418], 'inhibitors': [107, 421], 'are': [108], 'currently': [109, 313], 'clinical': [111, 315], 'trials': [112], 'for': [113, 121, 212, 363, 426], 'RCC.': [114], 'isolate': [116], 'additional': [117], 'compounds': [120, 194, 228, 273], 'use': [122], 'research': [124], 'tools': [125], 'drug': [127, 384], 'development': [128, 385, 416], 'leads,': [129, 289], 'cell-based': [131], 'high-throughput': [132], 'screen': [133], '(HTS)': [134], 'NCI': [137], 'Natural': [138], 'Products': [139], 'Repository': [140], 'was': [141, 294], 'performed.': [142], 'Stably': [143], 'transformed': [144], 'clones': [145], 'human': [148, 161], 'ccRCC-derived': [149], 'line': [151], '786-0': [152, 224], 'expressing': [153], 'luciferase': [155], 'reporter': [156], 'construct': [157], 'downstream': [158], 'vascular': [162], 'endothelial': [163], 'growth': [164], 'factor': [165], '(VEGF)': [166], 'promoter': [168], 'were': [169, 185, 209, 264, 346], 'used': [170, 295], 'identify': [172, 268], 'natural': [173, 419], 'product': [174, 420], 'samples': [175], 'inhibitory': [177], 'activity': [178], 'minimal': [180], 'cellular': [181], 'toxicity.': [182, 206], 'HTS': [183, 288, 344], 'leads': [184, 345], 'chromatographically': [186], 'separated': [187], 'into': [188], 'component': [189], 'structures': [190], 'yielding': [191], '~40': [192], 'pure': [193], 'micromolar': [196, 236], 'or': [197, 262], 'submicromolar': [198], 'IC50': [199], 'values,': [200], '>80%': [201], 'inhibition,': [202], '<10%': [204], 'These': [207], 'hits': [208], 'then': [210], 'screened': [211], 'their': [213], 'ability': [214], 'inhibit': [216], 'VEGF-A': [217], 'protein': [218, 373], 'secretion': [219, 234], 'by': [220], 'VHL-': [221], 'HIF1A-negative': [223], 'cells,': [225], 'several': [227, 249], 'showed': [229], '>90%': [230], 'inhibition': [231], 'VEGF': [233, 275], 'at': [235], 'doses': [237], 'under': [238], 'conditions.': [240], 'Patterns': [241], 'mRNA': [243], 'expression': [244], 'HIF-1α,': [246, 366], 'HIF-2α,': [247], 'HIF': [250, 260], 'target': [251, 282], 'genes': [252], 'lines': [255], 'engineered': [256], 'express': [258], 'either': [259], 'alone': [261], 'both': [263], 'studied': [265], 'help': [267], 'HIF-2α-selective': [269], 'inhibitors.': [270], 'Several': [271], 'lead': [272], 'reduced': [274], 'secretion,': [278], 'downregulated': [280], 'genes.': [283], 'further': [285], 'characterize': [286], 'ICM-Pro': [290], 'protein/small-molecule': [291], 'docking': [292, 340], 'software': [293], 'dock': [297], 'ligands': [299], 'interest': [301], 'high-resolution': [303], '3D': [307], 'structures.': [308], 'The': [309, 413], 'inhibitor': [312], 'undergoing': [314], 'investigation,': [316], 'PT2385,': [317], 'has': [318], 'been': [319, 352], 'found': [320], 'bind': [322], 'directly': [323], 'hydrophobic': [326], 'pocket': [327], 'HIF-2α:ARNT': [330], 'dimerization.': [331], 'Using': [332], 'PT2385': [334], 'binding': [335], 'mode': [336, 377], 'benchmark,': [339], 'performed': [347], 'results': [350], 'have': [351], 'linked': [353], 'empirical': [355], 'data': [356], 'effort': [359], 'explain': [361], 'selectivity': [362], 'over': [365], 'reveal': [367], 'key': [368], 'favorable': [369], 'interactions': [370], 'between': [371], 'ligand,': [375], 'define': [376], 'action,': [379], 'aid': [381], 'future': [383], 'studies.': [386], 'Citation': [387], 'Format:': [388], 'Molly': [389], 'M.': [390, 399], 'Lee,': [391], 'Daniel': [392], 'C.': [393, 396], 'Rabe,': [394], 'Tawnya': [395], 'McKee,': [397], 'Girma': [398], 'Woldemichael,': [400], 'James': [401, 404], 'R.': [402], 'Vasselli,': [403], 'B.': [405], 'McMahon,': [406], 'W.': [407], 'Marston': [408], 'Linehan,': [409], 'Donald': [410], 'P.': [411], 'Bottaro.': [412], 'identification': [414], 'factor-2α': [425], 'treatment': [428], '[abstract].': [433], 'In:': [434], 'Proceedings': [435], 'AACR-NCI-EORTC': [438], 'International': [439], 'Conference:': [440], 'Molecular': [441], 'Targets': [442], 'Cancer': [444, 455], 'Therapeutics;': [445], '2017': [446], 'Oct': [447], '26-30;': [448], 'Philadelphia,': [449], 'PA.': [450], 'Philadelphia': [451], '(PA):': [452], 'AACR;': [453], 'Mol': [454], 'Ther': [456], '2018;17(1': [457], 'Suppl):Abstract': [458], 'nr': [459], 'A127.': [460]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2786049742', 'counts_by_year': [], 'updated_date': '2024-12-13T11:48:50.235066', 'created_date': '2018-02-23'}